AdaptHealth Corp. — Director's Dealing 2021

Feb 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AdaptHealth Corp. (AHCO)
CIK: 0001725255
Period of Report: 2021-01-28

Reporting Person: McGee Luke (Director, Co-Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-28	Employee Stock Option (right to buy)	$11.50	A	416667	Acquired	2029-12-19	Class A Common Stock (416667)	Direct
2021-01-28	Employee Stock Option (right to buy)	$42.61	A	66600	Acquired	2026-01-28	Class A Common Stock (66600)	Direct
2021-01-28	Employee Stock Option (right to buy)	$48.17	A	77700	Acquired	2026-01-28	Class A Common Stock (77700)	Direct
2021-01-28	Employee Stock Option (right to buy)	$53.72	A	90090	Acquired	2026-01-28	Class A Common Stock (90090)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	296250	Direct
Class A Common Stock	716594	Indirect
Class A Common Stock	1793883	Indirect
Class A Common Stock	1196703	Indirect

Footnotes

F1: Securities held directly by 2321 Capital LLC. Includes 49,650 shares issued as contingent consideration pursuant to the Agreement and Plan of Merger, dated as of July 8, 2019, as amended, by and among the issuer, BM AH Holdings, LLC, Access Point Medical, Inc., DFB Merger Sub LLC, AdaptHealth Holdings LLC, Clifton Bay Offshore Investments L.P., BlueMountain Foinaven Master Fund L.P., BMSB L.P., BlueMountain Fursan Fund L.P. and AH Representative LLC (the "Merger Agreement").

F2: Securities held directly by Fresh Pond Investment LLC. Includes 41,827 shares issued as contingent consideration pursuant to the transactions contemplated by the Merger Agreement.

F3: Securities held directly by LBM DBE Holdings LLC. Includes 27,903 shares issued as contingent consideration pursuant to the transactions contemplated by the Merger Agreement.

F4: On December 19, 2019, the reporting person was granted an option to purchase 1,250,000 shares of Class A Common Stock of the issuer. The option vests in three equal annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2020, 2021 and 2022. The performance criteria for 2020 were met, resulting in vesting of the option as to 416,667 shares.

F5: Options vest in three equal annual installments, beginning on January 28, 2022

F6: Options vest in three equal annual installments, beginning on January 28, 2022

F7: Options vest in three equal annual installments, beginning on January 28, 2022